BioAtla (BCAB) Gains from Investment Securities (2024 - 2026)
BioAtla's (BCAB) quarterly Gains from Investment Securities came in at -$2.7 million in Q1 2026, down 42.23% year-on-year from -$4.6 million in Q1 2025, and down 221.78% quarter-over-quarter from -$831000.0 in Q4 2025.
BioAtla (BCAB) Gains from Investment Securities (2024 - 2026) Analysis & Trends
BioAtla's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- On a quarterly basis, Gains from Investment Securities fell 42.23% year-over-year to -$2.7 million in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 59.47% increase from a year earlier, with the FY2025 full-year figure at -$295000.0, up 63.44% from the prior year.
- Gains from Investment Securities slipped to -$2.7 million in Q1 2026 per BCAB's latest filing, from -$831000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.1 million in Q3 2025 and bottomed at -$2.7 million in Q1 2026.
- The 3-year median for Gains from Investment Securities is -$819000.0 (2024), against an average of -$629333.3.
- Across the five-year window, Gains from Investment Securities retreated 2.97% in 2025 and tumbled 42.23% in 2026, its largest moves.
- Year by year, Gains from Investment Securities stood at -$807000.0 in 2024, then fell by 2.97% to -$831000.0 in 2025, then sank by 221.78% to -$2.7 million in 2026.
- Per Business Quant, the three latest BCAB Gains from Investment Securities figures stand at -$2.7 million (Q1 2026), -$831000.0 (Q4 2025), and $2.1 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.67 Mn |
| Mar 31, 2026 | -2.67 Mn |
| Dec 31, 2025 | -831,000.00 |
| Dec 31, 2025 | -831,000.00 |
| Sep 30, 2025 | 2.12 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 297,000.00 |
| Mar 31, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | -807,000.00 |
| Dec 31, 2024 | -807,000.00 |